IBM App Connect Enterprise up to 11.0.0.24/12.0.11.0 excessive authentication
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 8.0 | $0-$5k | 0.00 |
Summary
A vulnerability was found in IBM App Connect Enterprise up to 11.0.0.24/12.0.11.0. It has been declared as problematic. Affected by this vulnerability is an unknown functionality. The manipulation results in excessive authentication. This vulnerability is known as CVE-2024-22317. It is possible to launch the attack remotely. No exploit is available. It is recommended to upgrade the affected component.
Details
A vulnerability classified as critical has been found in IBM App Connect Enterprise up to 11.0.0.24/12.0.11.0. Affected is some unknown processing. The manipulation with an unknown input leads to a excessive authentication vulnerability. CWE is classifying the issue as CWE-307. The product does not implement sufficient measures to prevent multiple failed authentication attempts within a short time frame, making it more susceptible to brute force attacks. This is going to have an impact on confidentiality, integrity, and availability. CVE summarizes:
IBM App Connect Enterprise 11.0.0.1 through 11.0.0.24 and 12.0.1.0 through 12.0.11.0 could allow a remote attacker to obtain sensitive information or cause a denial of service due to improper restriction of excessive authentication attempts. IBM X-Force ID: 279143.
The weakness was published 01/18/2024. The advisory is shared for download at ibm.com. This vulnerability is traded as CVE-2024-22317 since 01/08/2024. There are neither technical details nor an exploit publicly available. The MITRE ATT&CK project declares the attack technique as T1110.001.
Upgrading eliminates this vulnerability.
The vulnerability is also documented in the vulnerability database at X-Force (279143). Once again VulDB remains the best source for vulnerability data.
Product
Vendor
Name
Version
- 11.0.0.0
- 11.0.0.1
- 11.0.0.2
- 11.0.0.3
- 11.0.0.4
- 11.0.0.5
- 11.0.0.6
- 11.0.0.7
- 11.0.0.8
- 11.0.0.9
- 11.0.0.10
- 11.0.0.11
- 11.0.0.12
- 11.0.0.13
- 11.0.0.14
- 11.0.0.15
- 11.0.0.16
- 11.0.0.17
- 11.0.0.18
- 11.0.0.19
- 11.0.0.20
- 11.0.0.21
- 11.0.0.22
- 11.0.0.23
- 11.0.0.24
- 12.0.0
- 12.0.1
- 12.0.2
- 12.0.3
- 12.0.4
- 12.0.5
- 12.0.6
- 12.0.7
- 12.0.8
- 12.0.9
- 12.0.10
- 12.0.11.0
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 8.2VulDB Meta Temp Score: 8.0
VulDB Base Score: 7.3
VulDB Temp Score: 7.0
VulDB Vector: 🔍
VulDB Reliability: 🔍
CNA Base Score: 9.1
CNA Vector (IBM Corporation): 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
Exploiting
Class: Excessive authenticationCWE: CWE-307 / CWE-799 / CWE-400
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔍
Timeline
01/08/2024 🔍01/18/2024 🔍
01/18/2024 🔍
02/12/2024 🔍
Sources
Vendor: ibm.comAdvisory: ibm.com
Status: Confirmed
CVE: CVE-2024-22317 (🔍)
GCVE (CVE): GCVE-0-2024-22317
GCVE (VulDB): GCVE-100-251460
X-Force: 279143
Entry
Created: 01/18/2024 14:58Updated: 02/12/2024 10:53
Changes: 01/18/2024 14:58 (49), 02/12/2024 10:53 (1)
Complete: 🔍
Cache ID: 216::103
Once again VulDB remains the best source for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.